Publikācijas » 2004 » Scopus datu bāzē indeksētās publikācijas

Rezultātu skaits lapā  
41Sobolev A.; *Franssen M.C.R.; Duburs G.; De Groot A.E. Chemoenzymatic synthesis of enantiopure 1,4-dihydropyridine derivatives. Biocatal. Biotransform. 2004, 22(4), 231-252.      

42Kalme Z.A.; Zhalubovskis R.A.; Shmidlers A.; Celmiņš J.; Duburs G. Synthesis of 6-bromomethyl-substituted derivatives of pyridin-2(1H)-ones and their reaction with nucleophiles. Chem. Heterocycl. Compd. 2004, 40(7), 862-868.      

43Briede J.; Stivrina M.; Stoldere D.; Bisenieks E.; Uldriķis J.; Poikans J.; Makarova N.; *Duburs G. Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats. Cell Biochem. Funct. 2004, 22(4), 219-224.      

44Bisenieks E.; Uldriķis J.; Duburs G. Reaction of 3,5-carbonyl-substituted 1,4-dihydropyridines with hydrazine hydrate. Chem. Heterocycl. Compd. 2004, 40(7), 869-875.      

45Krauze A.; Baumane L.; Sile L.; Chernova L.; Viļums M.; Vitolina R.; Duburs G.; Stradiņš J. Synthesis, cardiovascular activity, and electrochemical oxidation of nitriles of 5-ethoxycarbonyl-2-methylthio-1,4-dihydropyridine-3-carboxylic acid. Chem. Heterocycl. Compd. 2004, 40(7), 876-887.      

46*Sjakste N.; Kleschyov A.L.; Boucher J.-L.; Baumane L.; Dzintare M.; Meirena D.; Sjakste J.; Sydow K.; Munzel T.; Kalvinsh I. Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: Possible link to the antiischemic activities of mildronate. Eur. J. Pharmacol. 2004, 495(1), 67-73.      

47*Dambrova M.; Liepinsh E.; Kirjanova O.; Petrovska R.; Pugovich O.; Baumane L.; Uhlen S.; Kalvinsh I.; Oliver D.; Wikberg J.E.S. Investigations on the pharmacology of the cardioprotective guanidine ME10092. J. Cardiovasc. Pharmacol. 2004, 44(2), 178-186.      

48*Fernandes M.A.S.; Santos M.S.; Moreno A.J.M.; Duburs G.; Oliveira C.R.; Vicente J.A.F. Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability. J. Biochem. Mol. Toxicol. 2004, 18(3), 162-169.      

49Mutulis F.; Yahorava S.; Mutule I.; Yahorau A.; Liepinsh E.; Kopantshuk S.; Veiksina S.; Tars K.; Belyakov S.; Mishnev A.; Rinken A.; *Wikberg J.E.S. New substituted piperazines as ligands for melanocortin receptors. Correlation to the X-ray structure of "THIQ". J. Med. Chem. 2004, 47(18), 4613-4626.      

50*Sjakste N.; Sjakste T.; Vikmanis U. Role of the nuclear matrix proteins in malignant transformation and cancer diagnosis. Exp. Oncol. 2004, 26(3), 170-178.      

Rezultātu skaits lapā